| Closed |
S1801 |
Ph II Ramdomization for Clinically Detectable Stage III-IV High-risk Melanoma |
12/6/2018 |
5/5/2022 |
100% |
|
|
| Closed |
S0713 |
Ph II Rectal Pre-Operative ChemoRT |
2/1/2009 |
4/15/2013 |
94% |
|
Published
|
| Closed |
S1507 |
Ph II Tram + doce with kras NSCLC + and PD |
7/18/2016 |
3/15/2018 |
100% |
|
|
| Open |
S1918 |
Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL |
3/19/2021 |
|
32% |
|
|
| Closed |
S0927 |
Ph III Omega-3 fatty acid/placebo Breast Cancer |
2/1/2012 |
2/1/2013 |
100% |
|
Published
|
| Closed |
S1202 |
Ph III Study of Duloxetine for AI-associated musculoskleteal symptoms for Early Stage BrCa |
5/15/2013 |
10/1/2015 |
100% |
|
Published
|
| Closed |
S1222 |
Ph. III Randomized Trial of fulvestrant +/- exemestane +/- everolimus in HR+ postmenopausal Stage IV |
5/9/2014 |
10/15/2015 |
4% |
|
|
| Closed |
S1207 |
Ph. III Randomized, Everolimus in high risk, hormone receptor positive, HER2 negative patients. |
9/3/2013 |
5/1/2019 |
100% |
|
|
| Closed |
SWOG-9225 |
Pharmacokinetics of Isotretinoin or All Trans Retinoic Acid: An Ancillary Study to SWOG-9132 |
9/15/1992 |
6/1/1996 |
|
|
Published
|
| Closed |
S0355 |
Phase I Pharmacokinetic Study |
11/1/2003 |
8/15/2006 |
100% |
|
Published
|
| Closed |
S0528 |
Phase I Study of Lapatinib and Everolimus in Advanced Solid Tumors |
9/1/2006 |
8/25/2009 |
100% |
|
Published
|
| Closed |
SWOG-8746 |
Phase I Trial of Dose Intensive Chemotherapy Combined with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Breast Cancer |
9/1/1988 |
9/1/1992 |
67% |
|
Published
|
| Closed |
SWOG-8902 |
Phase I Trial of Doxorubicin plus Carboplatin with GM-CSF in Patients with Advanced, Previously Treated Cancer |
4/15/1990 |
5/1/1992 |
70% |
|
Published
|
| Closed |
SWOG-8922 |
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor in Advanced Soft Tissue Sarcomas |
9/15/1990 |
9/15/1992 |
28% |
|
Published
|
| Closed |
SWOG-9128 |
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor/Peripheral Blood Progenitor Cell Infusion in Advanced Soft Tissue Sarcomas |
9/1/1992 |
12/1/1994 |
47% |
|
|
| Closed |
SWOG-8825 |
Phase I Trial of Intravenous Bolus Melphalan With GM-CSF |
12/15/1988 |
12/1/1990 |
87% |
|
Published
|
| Closed |
SWOG-8903 |
Phase I Trial of Promace-CytoBOM with GM-CSF for Treatment of Non-Hodgkin's Lymphoma |
11/15/1989 |
11/1/1993 |
93% |
|
Published
|
| Closed |
S0806 |
Phase I/II DLBCL Vorinostat with R-CHOP |
11/15/2010 |
10/1/2013 |
100% |
|
Published
|
| Closed |
S0720 |
Phase II Adjuvant NSCLC |
11/15/2008 |
5/15/2012 |
100% |
|
Published
|
| Closed |
S0535 |
Phase II ATRA, Arsenic and Mylotarg for Untreated High-Risk APL |
11/15/2007 |
|
100% |
|
|
